Vault-13

ATYR PHARMA INC LIFE

COM · Common Stock · CUSIP 002120103

1 institutional holders +0 vs Q2 2021
130,572130.6k shares reported held*
$1.2mreported value*
0 new 0 added 0 reduced 0 sold out net bought ≈ $0

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $9.08.

Trends to Q3 2021

Institutional holders

Managers reporting a position, each quarter

012Q4 19: 2Q1 20: 2Q2 20: 1Q3 20: 1Q4 20: 1Q1 21: 1Q2 21: 1Q3 21: 11Q4 19Q2 20Q4 20Q2 21Q3 21
Numbers
QuarterHolders
Q4 20192
Q1 20202
Q2 20201
Q3 20201
Q4 20201
Q1 20211
Q2 20211
Q3 20211

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q1 20: 0 bought or addedQ1 20: 0 cut or sold outQ1 20Q2 20: 1 bought or addedQ2 20: 1 cut or sold outQ3 20: 0 bought or addedQ3 20: 0 cut or sold outQ3 20Q4 20: 0 bought or addedQ4 20: 0 cut or sold outQ1 21: 0 bought or addedQ1 21: 0 cut or sold outQ1 21Q2 21: 0 bought or addedQ2 21: 0 cut or sold outQ3 21: 0 bought or addedQ3 21: 0 cut or sold outQ3 21
Numbers
QuarterBought or addedCut or sold out
Q1 202000
Q2 202011
Q3 202000
Q4 202000
Q1 202100
Q2 202100
Q3 202100

Insider purchases and sales in Q3 2021

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q3 2021.

Holders, Q3 2021

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Polaris Venture Management Co. V, L.L.C. 8.42% of their portfolio Boston, MA 130,572130.6k $1.2m $1.2m 8.42% Unchanged